Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial. [electronic resource]
Producer: 20171221Description: 622-627 p. digitalISSN:- 1569-8041
- Adult
- Age Factors
- Aged
- Cisplatin -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Lymphoma -- mortality
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- mortality
- Salvage Therapy -- adverse effects
- Stem Cell Transplantation -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.